Literature DB >> 10752656

Telomerase, p53 and human papillomavirus infection in the uterine cervix.

P Nair1, P G Jayaprakash, M K Nair, M R Pillai.   

Abstract

Human papillomavirus infection is postulated to be a major risk factor for cervical cancer, while more recent data have stressed the clinical significance of telomerase expression during tumorigenesis. This study therefore looked for any relationship between telomerase expression, presence of human papillomavirus (HPV) and expression of the high-risk HPV E6 protein at various phases of tumor progression in the uterine cervix. In addition, accumulation of the p53 protein and total tissue proliferative fraction were also studied. Telomerase was detected using a modified TRAP (telomerase repeat amplification protocol) assay. Expression of p53, Ki 67 and E6 protein was evaluated by immunocytochemistry. Presence of mutant p53 was detected using a mutant-specific ELISA. Type of HPV infection was determined by polymerase chain reaction and Southern blot using type-specific primers and probes. There was a significant correlation between the expression of telomerase with histological grade (r = 0.646, p = 0.00003). Fisher's exact test analysis revealed that the odds ratio of a tissue sample expressing telomerase being a case (high-grade squamous intraepithelial lesion or invasive cancer) was 28.93 (p = 0.0001, 95% CI: 7.22, to 115.94). High-risk HPV-infected tissues and those expressing E6 showed increased telomerase expression (r = 0.555, p = 0.00001). Similarly, accumulation of p53 protein and increased cell proliferation (Ki 67 index) also correlated to the presence of telomerase (r = 0.661, p = 0.000004 for p53 and r = 0.647, p = 0.000003 for Ki 67). There was no correlation between telomerase expression and presence of p53 mutation. Activation of telomerase thus appears to be associated with high-risk-HPV infection, accumulation of inactive p53 protein and increased cell proliferation in cervical lesions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10752656     DOI: 10.1080/028418600430996

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

1.  Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.

Authors:  P L Cheah; L M Looi; M H Ng; V Sivanesaratnam
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

2.  Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell.

Authors:  Zhong-Ying Shen; Li-Yan Xu; En-Min Li; Wei-Jia Cai; Min-Hua Chen; Jian Shen; Yi Zeng
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

3.  Telomerase activity as a potential diagnostic marker for triage of abnormal Pap smears.

Authors:  Kevin A Ault; Heather K Allen; Stacia L Phillips; M Bridget Zimmerman; Aloysius J Klingelhutz
Journal:  J Low Genit Tract Dis       Date:  2005-04       Impact factor: 1.925

4.  Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma.

Authors:  Ni Sima; Liping Cai; Yuanfang Zhu; Wei Wang; Shixuan Wang; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

5.  Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer.

Authors:  M R Pillai; P Chacko; L A Kesari; P G Jayaprakash; H N Jayaram; A C Antony
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.